Lv3
284 积分 2021-02-20 加入
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
3天前
已完结
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth
25天前
已完结
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer
1个月前
已完结
Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells
1个月前
已完结
Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct patterns and potential markers of progression
4个月前
已完结
皖公网安备34019202002308
